Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Systemic Inflammatory Response Syndrome | 27 | 2024 | 621 | 4.430 |
Why?
|
Influenza, Human | 26 | 2024 | 1542 | 3.240 |
Why?
|
Sepsis | 23 | 2024 | 2610 | 2.400 |
Why?
|
Respiratory Syncytial Virus Infections | 10 | 2024 | 365 | 1.960 |
Why?
|
Respiratory Tract Infections | 12 | 2024 | 1014 | 1.840 |
Why?
|
Critical Care | 24 | 2024 | 2716 | 1.770 |
Why?
|
Critical Illness | 23 | 2024 | 2754 | 1.670 |
Why?
|
Intensive Care Units, Pediatric | 25 | 2024 | 1027 | 1.630 |
Why?
|
Acute Lung Injury | 8 | 2023 | 378 | 1.560 |
Why?
|
Respiration, Artificial | 33 | 2023 | 2725 | 1.350 |
Why?
|
Child | 142 | 2024 | 80960 | 1.280 |
Why?
|
Intensive Care Units | 22 | 2024 | 3800 | 1.250 |
Why?
|
Multiple Organ Failure | 9 | 2024 | 387 | 1.200 |
Why?
|
Shock, Septic | 8 | 2024 | 774 | 1.190 |
Why?
|
Mannose-Binding Lectin | 2 | 2019 | 146 | 1.110 |
Why?
|
Respiratory Insufficiency | 7 | 2023 | 1241 | 1.100 |
Why?
|
Pediatrics | 15 | 2020 | 3628 | 1.030 |
Why?
|
Ribavirin | 5 | 2010 | 395 | 1.010 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 3 | 2022 | 704 | 0.930 |
Why?
|
Infant | 60 | 2024 | 36556 | 0.930 |
Why?
|
Haplotypes | 6 | 2017 | 2725 | 0.930 |
Why?
|
Influenza A Virus, H1N1 Subtype | 5 | 2022 | 453 | 0.900 |
Why?
|
Vitamin D-Binding Protein | 2 | 2015 | 130 | 0.890 |
Why?
|
Influenza A virus | 4 | 2020 | 460 | 0.870 |
Why?
|
Catheterization, Central Venous | 13 | 2011 | 536 | 0.870 |
Why?
|
Child, Preschool | 62 | 2024 | 42683 | 0.830 |
Why?
|
Pneumonia, Staphylococcal | 2 | 2022 | 39 | 0.830 |
Why?
|
Ventilator Weaning | 6 | 2010 | 170 | 0.800 |
Why?
|
Interferon Type I | 2 | 2023 | 569 | 0.790 |
Why?
|
Bacterial Infections | 4 | 2023 | 1397 | 0.790 |
Why?
|
Antiviral Agents | 8 | 2020 | 3070 | 0.730 |
Why?
|
Water-Electrolyte Balance | 3 | 2013 | 326 | 0.720 |
Why?
|
Randomized Controlled Trials as Topic | 18 | 2017 | 10400 | 0.710 |
Why?
|
Catheter-Related Infections | 5 | 2016 | 275 | 0.700 |
Why?
|
Respiratory Syncytial Viruses | 3 | 2023 | 168 | 0.690 |
Why?
|
Connective Tissue Diseases | 4 | 2023 | 285 | 0.680 |
Why?
|
Adolescent | 72 | 2024 | 89244 | 0.670 |
Why?
|
Immunity, Innate | 5 | 2022 | 3080 | 0.660 |
Why?
|
Heart Arrest | 3 | 2016 | 1515 | 0.640 |
Why?
|
Humans | 218 | 2024 | 768970 | 0.630 |
Why?
|
Ventilator-Induced Lung Injury | 3 | 2019 | 135 | 0.620 |
Why?
|
Acetaminophen | 2 | 2021 | 556 | 0.620 |
Why?
|
Bacteremia | 6 | 2016 | 985 | 0.610 |
Why?
|
Pulmonary Surfactants | 5 | 2023 | 169 | 0.600 |
Why?
|
Medical Staff, Hospital | 4 | 2020 | 603 | 0.590 |
Why?
|
Enterovirus D, Human | 1 | 2016 | 5 | 0.560 |
Why?
|
Anti-Bacterial Agents | 6 | 2020 | 7478 | 0.560 |
Why?
|
Bronchiolitis, Viral | 2 | 2015 | 82 | 0.550 |
Why?
|
Pandemics | 12 | 2024 | 8749 | 0.530 |
Why?
|
Erythrocyte Transfusion | 4 | 2016 | 575 | 0.530 |
Why?
|
Staphylococcal Infections | 3 | 2022 | 1398 | 0.520 |
Why?
|
Ethics Committees, Research | 3 | 2014 | 196 | 0.520 |
Why?
|
Drug Utilization | 2 | 2019 | 1191 | 0.520 |
Why?
|
Research Personnel | 3 | 2022 | 590 | 0.520 |
Why?
|
Hospitalization | 26 | 2024 | 10847 | 0.520 |
Why?
|
Enterovirus Infections | 1 | 2016 | 74 | 0.520 |
Why?
|
Immunoglobulins, Intravenous | 5 | 2023 | 667 | 0.510 |
Why?
|
Multicenter Studies as Topic | 5 | 2014 | 1737 | 0.510 |
Why?
|
Analgesics, Non-Narcotic | 1 | 2019 | 371 | 0.510 |
Why?
|
Candidemia | 1 | 2016 | 40 | 0.510 |
Why?
|
Orthomyxoviridae | 2 | 2016 | 148 | 0.500 |
Why?
|
Vancomycin | 1 | 2019 | 506 | 0.500 |
Why?
|
Journal Impact Factor | 1 | 2016 | 156 | 0.480 |
Why?
|
Personnel Staffing and Scheduling | 2 | 2017 | 497 | 0.480 |
Why?
|
Adrenergic alpha-Agonists | 1 | 2015 | 177 | 0.470 |
Why?
|
Unconsciousness | 2 | 2015 | 251 | 0.470 |
Why?
|
Vitamin D Deficiency | 2 | 2015 | 1388 | 0.460 |
Why?
|
Fluid Therapy | 4 | 2020 | 587 | 0.460 |
Why?
|
Evidence-Based Medicine | 13 | 2021 | 3709 | 0.460 |
Why?
|
Clinical Trials as Topic | 10 | 2020 | 8055 | 0.450 |
Why?
|
Adrenergic beta-Agonists | 1 | 2015 | 347 | 0.450 |
Why?
|
Infant, Newborn | 32 | 2024 | 26428 | 0.440 |
Why?
|
Pneumonia, Viral | 5 | 2022 | 3241 | 0.420 |
Why?
|
Ventilators, Mechanical | 4 | 2005 | 292 | 0.410 |
Why?
|
Influenza Vaccines | 4 | 2022 | 781 | 0.410 |
Why?
|
Oseltamivir | 1 | 2012 | 76 | 0.400 |
Why?
|
Catheters, Indwelling | 6 | 2005 | 436 | 0.400 |
Why?
|
Polymorphism, Genetic | 5 | 2005 | 4251 | 0.400 |
Why?
|
Cross Infection | 10 | 2011 | 1425 | 0.390 |
Why?
|
Epinephrine | 1 | 2015 | 794 | 0.390 |
Why?
|
RNA-Binding Proteins | 2 | 2017 | 1891 | 0.380 |
Why?
|
Respiratory Syncytial Virus, Human | 1 | 2014 | 149 | 0.380 |
Why?
|
Polymorphism, Single Nucleotide | 8 | 2022 | 16053 | 0.380 |
Why?
|
Out-of-Hospital Cardiac Arrest | 1 | 2015 | 340 | 0.370 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2016 | 620 | 0.370 |
Why?
|
Hospital Bed Capacity | 2 | 2019 | 205 | 0.360 |
Why?
|
Drug Costs | 1 | 2019 | 1198 | 0.360 |
Why?
|
Coronavirus Infections | 4 | 2020 | 3118 | 0.360 |
Why?
|
Respiratory Distress Syndrome, Newborn | 2 | 2003 | 239 | 0.360 |
Why?
|
Hospital Information Systems | 2 | 2007 | 394 | 0.360 |
Why?
|
Hemoglobins | 2 | 2014 | 1531 | 0.350 |
Why?
|
Hypothermia, Induced | 1 | 2015 | 756 | 0.340 |
Why?
|
Genetic Predisposition to Disease | 9 | 2023 | 18068 | 0.340 |
Why?
|
Continuity of Patient Care | 1 | 2017 | 1076 | 0.340 |
Why?
|
Virus Diseases | 1 | 2016 | 724 | 0.340 |
Why?
|
Mutation, Missense | 1 | 2019 | 2592 | 0.340 |
Why?
|
Acute Kidney Injury | 1 | 2022 | 1936 | 0.330 |
Why?
|
Heparin | 5 | 2014 | 1636 | 0.320 |
Why?
|
Clinical Protocols | 3 | 2005 | 1445 | 0.320 |
Why?
|
Hospitals, Pediatric | 7 | 2022 | 1876 | 0.320 |
Why?
|
Female | 79 | 2024 | 397515 | 0.310 |
Why?
|
Male | 72 | 2024 | 365203 | 0.310 |
Why?
|
Burnout, Professional | 1 | 2017 | 711 | 0.310 |
Why?
|
Respiratory Sounds | 4 | 2010 | 702 | 0.300 |
Why?
|
Glucocorticoids | 6 | 2023 | 2167 | 0.300 |
Why?
|
Anticoagulants | 8 | 2021 | 4850 | 0.300 |
Why?
|
Euthanasia, Passive | 2 | 1999 | 64 | 0.300 |
Why?
|
Anesthesia | 2 | 2016 | 1596 | 0.290 |
Why?
|
Decision Support Techniques | 6 | 2009 | 2008 | 0.290 |
Why?
|
Nervous System Diseases | 3 | 2023 | 1665 | 0.290 |
Why?
|
Vaccines, Synthetic | 4 | 2022 | 622 | 0.280 |
Why?
|
Decision Support Systems, Clinical | 2 | 2022 | 1178 | 0.280 |
Why?
|
United States | 40 | 2024 | 73186 | 0.280 |
Why?
|
Vitamin D | 3 | 2015 | 3311 | 0.270 |
Why?
|
Syndrome | 3 | 2024 | 3274 | 0.270 |
Why?
|
Prospective Studies | 19 | 2023 | 54962 | 0.270 |
Why?
|
Biomedical Research | 3 | 2016 | 3463 | 0.270 |
Why?
|
Autoantibodies | 3 | 2024 | 2120 | 0.270 |
Why?
|
Respiration Disorders | 3 | 2009 | 365 | 0.260 |
Why?
|
Catheterization, Peripheral | 5 | 2011 | 347 | 0.250 |
Why?
|
Resuscitation | 3 | 2022 | 679 | 0.250 |
Why?
|
Venous Thrombosis | 2 | 2014 | 1321 | 0.250 |
Why?
|
Lymphotoxin-alpha | 1 | 2005 | 94 | 0.250 |
Why?
|
Personnel, Hospital | 1 | 2007 | 285 | 0.240 |
Why?
|
Superinfection | 1 | 2004 | 62 | 0.230 |
Why?
|
Lung Compliance | 1 | 2004 | 207 | 0.230 |
Why?
|
Asthma | 5 | 2022 | 6293 | 0.230 |
Why?
|
Equipment Contamination | 5 | 2002 | 183 | 0.230 |
Why?
|
Herpes Genitalis | 2 | 1996 | 149 | 0.220 |
Why?
|
Hospital Mortality | 6 | 2024 | 5369 | 0.220 |
Why?
|
Infection Control | 7 | 2011 | 985 | 0.220 |
Why?
|
Tidal Volume | 2 | 2013 | 518 | 0.220 |
Why?
|
Adrenal Cortex Hormones | 4 | 2010 | 1892 | 0.220 |
Why?
|
Membrane Proteins | 2 | 2017 | 7885 | 0.220 |
Why?
|
Haploinsufficiency | 2 | 2022 | 334 | 0.220 |
Why?
|
Molecular Mimicry | 1 | 2024 | 213 | 0.220 |
Why?
|
Guidelines as Topic | 2 | 2020 | 1399 | 0.210 |
Why?
|
Pregnancy Complications, Infectious | 4 | 2022 | 2190 | 0.210 |
Why?
|
Severity of Illness Index | 8 | 2022 | 15951 | 0.210 |
Why?
|
NF-kappa B p52 Subunit | 1 | 2022 | 35 | 0.210 |
Why?
|
Drug Industry | 1 | 2009 | 793 | 0.210 |
Why?
|
Chromosomes, Human, Pair 5 | 1 | 2004 | 387 | 0.210 |
Why?
|
Meningitis, Aseptic | 1 | 2023 | 59 | 0.210 |
Why?
|
Medical Records Systems, Computerized | 2 | 2007 | 1196 | 0.200 |
Why?
|
Macrophage Activation Syndrome | 1 | 2023 | 124 | 0.200 |
Why?
|
Withholding Treatment | 1 | 2007 | 620 | 0.200 |
Why?
|
Hospital Restructuring | 1 | 2002 | 11 | 0.200 |
Why?
|
Cross Reactions | 1 | 2024 | 828 | 0.200 |
Why?
|
Extracorporeal Membrane Oxygenation | 3 | 2023 | 1483 | 0.200 |
Why?
|
Multigene Family | 1 | 2005 | 1082 | 0.200 |
Why?
|
Vaccination | 9 | 2023 | 3438 | 0.200 |
Why?
|
Interleukin-12 | 1 | 2004 | 577 | 0.190 |
Why?
|
Patient Selection | 5 | 2020 | 4265 | 0.190 |
Why?
|
Monitoring, Physiologic | 2 | 2007 | 1798 | 0.190 |
Why?
|
Interleukin 1 Receptor Antagonist Protein | 1 | 2023 | 299 | 0.190 |
Why?
|
Data Interpretation, Statistical | 2 | 2009 | 2714 | 0.190 |
Why?
|
Immunity, Maternally-Acquired | 1 | 2022 | 112 | 0.190 |
Why?
|
Practice Guidelines as Topic | 5 | 2014 | 7460 | 0.190 |
Why?
|
Guillain-Barre Syndrome | 1 | 2023 | 127 | 0.190 |
Why?
|
Immunoglobulins | 1 | 2004 | 855 | 0.190 |
Why?
|
Age Factors | 9 | 2022 | 18435 | 0.180 |
Why?
|
Lymphopenia | 1 | 2023 | 300 | 0.180 |
Why?
|
Heparin, Low-Molecular-Weight | 2 | 2014 | 344 | 0.180 |
Why?
|
Models, Anatomic | 1 | 2004 | 683 | 0.180 |
Why?
|
Probability | 5 | 2009 | 2483 | 0.180 |
Why?
|
Child, Hospitalized | 1 | 2022 | 182 | 0.170 |
Why?
|
Antibodies, Viral | 4 | 2024 | 3215 | 0.170 |
Why?
|
Tachycardia, Supraventricular | 1 | 2022 | 273 | 0.170 |
Why?
|
Life Support Care | 2 | 2022 | 226 | 0.170 |
Why?
|
Young Adult | 14 | 2024 | 60131 | 0.160 |
Why?
|
Steroids | 1 | 2004 | 938 | 0.160 |
Why?
|
Therapy, Computer-Assisted | 2 | 1998 | 265 | 0.160 |
Why?
|
Case-Control Studies | 12 | 2023 | 22296 | 0.160 |
Why?
|
Intubation, Intratracheal | 3 | 2010 | 1359 | 0.160 |
Why?
|
Software Design | 2 | 1998 | 173 | 0.160 |
Why?
|
Immunocompromised Host | 1 | 2024 | 863 | 0.160 |
Why?
|
Anemia, Hemolytic, Autoimmune | 1 | 2020 | 147 | 0.160 |
Why?
|
Decision Making, Computer-Assisted | 1 | 1999 | 146 | 0.160 |
Why?
|
Asymptomatic Diseases | 1 | 2022 | 590 | 0.160 |
Why?
|
Retrospective Studies | 18 | 2024 | 81903 | 0.150 |
Why?
|
Adolescent Development | 1 | 2022 | 279 | 0.150 |
Why?
|
Tissue and Organ Procurement | 1 | 2007 | 986 | 0.150 |
Why?
|
Causality | 1 | 2024 | 1256 | 0.150 |
Why?
|
Anti-Infective Agents | 2 | 2023 | 984 | 0.150 |
Why?
|
Venous Thromboembolism | 1 | 2011 | 1881 | 0.150 |
Why?
|
Bronchiolitis | 1 | 2004 | 492 | 0.150 |
Why?
|
Informed Consent | 3 | 2014 | 1010 | 0.150 |
Why?
|
Epitopes | 1 | 2024 | 2529 | 0.150 |
Why?
|
Pulmonary Embolism | 1 | 2011 | 2600 | 0.140 |
Why?
|
Catheterization, Swan-Ganz | 1 | 1998 | 87 | 0.140 |
Why?
|
Receptors, Immunologic | 2 | 2022 | 1418 | 0.140 |
Why?
|
Thrombophlebitis | 1 | 1998 | 289 | 0.140 |
Why?
|
Health Services Research | 2 | 2010 | 1818 | 0.140 |
Why?
|
Lung Injury | 1 | 2021 | 433 | 0.140 |
Why?
|
Injections, Intravenous | 1 | 2019 | 1379 | 0.140 |
Why?
|
Hemolysin Proteins | 1 | 2016 | 113 | 0.130 |
Why?
|
Aftercare | 4 | 2022 | 921 | 0.130 |
Why?
|
Host-Pathogen Interactions | 2 | 2022 | 1469 | 0.130 |
Why?
|
Toll-Like Receptor 4 | 1 | 2020 | 587 | 0.130 |
Why?
|
Interferon Regulatory Factor-3 | 1 | 2017 | 146 | 0.130 |
Why?
|
Enterovirus | 1 | 2016 | 69 | 0.130 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2020 | 4356 | 0.130 |
Why?
|
Health Care Rationing | 1 | 2019 | 435 | 0.130 |
Why?
|
Acute Disease | 5 | 2016 | 7245 | 0.130 |
Why?
|
Lung | 3 | 2024 | 10099 | 0.130 |
Why?
|
Length of Stay | 7 | 2020 | 6526 | 0.130 |
Why?
|
Cytokines | 4 | 2023 | 7453 | 0.130 |
Why?
|
Acyclovir | 1 | 1996 | 267 | 0.130 |
Why?
|
Leukocytes, Mononuclear | 1 | 2022 | 1855 | 0.130 |
Why?
|
Risk Factors | 15 | 2023 | 74976 | 0.130 |
Why?
|
History, 21st Century | 1 | 2022 | 1575 | 0.130 |
Why?
|
Consensus | 5 | 2024 | 3214 | 0.120 |
Why?
|
Persistent Vegetative State | 1 | 1998 | 275 | 0.120 |
Why?
|
Postoperative Nausea and Vomiting | 1 | 2016 | 128 | 0.120 |
Why?
|
Phenotype | 5 | 2024 | 16731 | 0.120 |
Why?
|
Myocarditis | 1 | 2023 | 803 | 0.120 |
Why?
|
Biological Availability | 1 | 2015 | 392 | 0.120 |
Why?
|
Survival Analysis | 5 | 2019 | 10115 | 0.120 |
Why?
|
Hematopoietic Stem Cell Transplantation | 3 | 2022 | 5716 | 0.120 |
Why?
|
Amino Acid Substitution | 1 | 2019 | 1742 | 0.120 |
Why?
|
Receptors, Adrenergic, beta-2 | 1 | 2015 | 216 | 0.120 |
Why?
|
Ultrasonography, Doppler | 1 | 1996 | 463 | 0.120 |
Why?
|
Hepatic Veno-Occlusive Disease | 1 | 2016 | 220 | 0.120 |
Why?
|
Disease Susceptibility | 1 | 2021 | 1794 | 0.120 |
Why?
|
Communicable Diseases | 1 | 2022 | 873 | 0.110 |
Why?
|
Treatment Outcome | 14 | 2021 | 65480 | 0.110 |
Why?
|
Interferons | 3 | 2023 | 720 | 0.110 |
Why?
|
Cohort Studies | 9 | 2023 | 41808 | 0.110 |
Why?
|
NF-kappa B | 1 | 2022 | 2492 | 0.110 |
Why?
|
Hyperglycemia | 1 | 2022 | 1389 | 0.110 |
Why?
|
Infectious Disease Transmission, Vertical | 2 | 2022 | 1360 | 0.110 |
Why?
|
Nursing Staff, Hospital | 1 | 1997 | 350 | 0.110 |
Why?
|
Prognosis | 7 | 2009 | 30046 | 0.110 |
Why?
|
Immunomodulation | 3 | 2023 | 549 | 0.110 |
Why?
|
Adult | 28 | 2023 | 223851 | 0.110 |
Why?
|
Fatty Alcohols | 1 | 2012 | 22 | 0.110 |
Why?
|
Heart Septal Defects, Atrial | 1 | 2016 | 452 | 0.110 |
Why?
|
Phosphatidylglycerols | 1 | 2012 | 35 | 0.100 |
Why?
|
Thrombosis | 2 | 2021 | 2956 | 0.100 |
Why?
|
Nasopharynx | 1 | 2016 | 420 | 0.100 |
Why?
|
Random Allocation | 1 | 2017 | 2394 | 0.100 |
Why?
|
Cluster Analysis | 3 | 2022 | 2732 | 0.100 |
Why?
|
Thrombocytopenia | 1 | 2020 | 1181 | 0.100 |
Why?
|
Protein Isoforms | 1 | 2017 | 1714 | 0.100 |
Why?
|
Homozygote | 1 | 2017 | 1780 | 0.100 |
Why?
|
Patient Discharge | 5 | 2022 | 3491 | 0.100 |
Why?
|
Risk Adjustment | 1 | 2016 | 603 | 0.100 |
Why?
|
Seasons | 3 | 2023 | 1524 | 0.100 |
Why?
|
Kidney Transplantation | 1 | 2007 | 4265 | 0.090 |
Why?
|
Quality Assurance, Health Care | 1 | 2002 | 2182 | 0.090 |
Why?
|
Confidence Intervals | 2 | 2012 | 2932 | 0.090 |
Why?
|
Statistics, Nonparametric | 3 | 2012 | 2862 | 0.090 |
Why?
|
RNA, Viral | 2 | 2017 | 2871 | 0.090 |
Why?
|
Specimen Handling | 1 | 2016 | 708 | 0.090 |
Why?
|
Bacterial Toxins | 1 | 2016 | 922 | 0.090 |
Why?
|
Drug Administration Schedule | 1 | 2019 | 4862 | 0.090 |
Why?
|
Databases, Factual | 3 | 2023 | 8094 | 0.090 |
Why?
|
Comorbidity | 2 | 2023 | 10592 | 0.090 |
Why?
|
Genetic Markers | 1 | 2017 | 2604 | 0.090 |
Why?
|
Antibodies, Bacterial | 1 | 2016 | 1478 | 0.090 |
Why?
|
Cross-Sectional Studies | 8 | 2023 | 26395 | 0.090 |
Why?
|
Croup | 1 | 2010 | 23 | 0.090 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2021 | 2145 | 0.090 |
Why?
|
Vascular Surgical Procedures | 1 | 1999 | 1515 | 0.090 |
Why?
|
Counseling | 1 | 1998 | 1554 | 0.090 |
Why?
|
Child Development | 1 | 2022 | 2336 | 0.090 |
Why?
|
Fibroblasts | 1 | 2020 | 4179 | 0.090 |
Why?
|
Disease Notification | 1 | 2010 | 95 | 0.080 |
Why?
|
Computers | 2 | 2022 | 592 | 0.080 |
Why?
|
Logistic Models | 5 | 2021 | 13318 | 0.080 |
Why?
|
Genotype | 5 | 2023 | 13048 | 0.080 |
Why?
|
Catheterization | 3 | 2002 | 1431 | 0.080 |
Why?
|
Point-of-Care Systems | 1 | 1998 | 1240 | 0.080 |
Why?
|
MEDLINE | 2 | 1999 | 119 | 0.080 |
Why?
|
Chemoprevention | 1 | 2011 | 326 | 0.080 |
Why?
|
Computer Simulation | 2 | 2017 | 6291 | 0.080 |
Why?
|
Adaptive Immunity | 1 | 2013 | 733 | 0.080 |
Why?
|
Chemokines | 1 | 2013 | 963 | 0.080 |
Why?
|
Stroke Volume | 4 | 2023 | 5622 | 0.080 |
Why?
|
Disease Progression | 5 | 2023 | 13674 | 0.080 |
Why?
|
RNA, Messenger | 4 | 2024 | 12806 | 0.080 |
Why?
|
Cesarean Section | 2 | 1996 | 1426 | 0.080 |
Why?
|
Periodicals as Topic | 1 | 1999 | 1470 | 0.070 |
Why?
|
Incidence | 4 | 2021 | 21547 | 0.070 |
Why?
|
Neutralization Tests | 2 | 2022 | 739 | 0.070 |
Why?
|
Research Design | 5 | 2020 | 6214 | 0.070 |
Why?
|
Combined Modality Therapy | 3 | 2021 | 8559 | 0.070 |
Why?
|
Promoter Regions, Genetic | 2 | 2017 | 5801 | 0.070 |
Why?
|
Age Distribution | 2 | 2021 | 2875 | 0.070 |
Why?
|
Medical Oncology | 1 | 1999 | 2350 | 0.070 |
Why?
|
Disease Outbreaks | 1 | 2016 | 1761 | 0.070 |
Why?
|
Chlamydia Infections | 1 | 1990 | 365 | 0.070 |
Why?
|
Repressor Proteins | 1 | 2017 | 2986 | 0.070 |
Why?
|
Hemorrhage | 2 | 2016 | 3466 | 0.070 |
Why?
|
Genetic Association Studies | 1 | 2015 | 2748 | 0.070 |
Why?
|
Respiratory Function Tests | 2 | 2004 | 1694 | 0.070 |
Why?
|
Vasoconstrictor Agents | 2 | 2020 | 657 | 0.070 |
Why?
|
Teaching | 1 | 1994 | 1171 | 0.070 |
Why?
|
Predictive Value of Tests | 4 | 2010 | 15471 | 0.070 |
Why?
|
Algorithms | 1 | 2007 | 14201 | 0.060 |
Why?
|
Ventricular Function, Left | 3 | 2023 | 3941 | 0.060 |
Why?
|
Evaluation Studies as Topic | 2 | 1998 | 1629 | 0.060 |
Why?
|
Anesthesiology | 1 | 2016 | 1137 | 0.060 |
Why?
|
Internet | 1 | 1998 | 3112 | 0.060 |
Why?
|
Fellowships and Scholarships | 2 | 2008 | 1134 | 0.060 |
Why?
|
Budgets | 1 | 2007 | 232 | 0.060 |
Why?
|
Biometry | 1 | 2008 | 570 | 0.060 |
Why?
|
Sorting Nexins | 1 | 2024 | 26 | 0.060 |
Why?
|
Interleukin-12 Subunit p40 | 1 | 2004 | 59 | 0.060 |
Why?
|
Cost-Benefit Analysis | 3 | 1996 | 5544 | 0.060 |
Why?
|
Microbiological Techniques | 1 | 2005 | 97 | 0.060 |
Why?
|
Carboxylic Ester Hydrolases | 1 | 2024 | 99 | 0.060 |
Why?
|
Oleic Acid | 1 | 2024 | 91 | 0.060 |
Why?
|
Pregnancy | 6 | 2023 | 30265 | 0.060 |
Why?
|
RNA, Messenger, Stored | 1 | 2023 | 5 | 0.060 |
Why?
|
Regression Analysis | 3 | 2021 | 6346 | 0.060 |
Why?
|
Quality of Life | 2 | 2023 | 13510 | 0.060 |
Why?
|
National Institutes of Health (U.S.) | 2 | 2024 | 794 | 0.060 |
Why?
|
Prejudice | 1 | 2008 | 574 | 0.050 |
Why?
|
Wounds and Injuries | 1 | 2016 | 2517 | 0.050 |
Why?
|
Research Support as Topic | 1 | 2008 | 696 | 0.050 |
Why?
|
Boston | 2 | 2014 | 9377 | 0.050 |
Why?
|
Brain Death | 1 | 2007 | 359 | 0.050 |
Why?
|
Infusions, Intravenous | 2 | 1998 | 2231 | 0.050 |
Why?
|
Puerto Rico | 1 | 2004 | 380 | 0.050 |
Why?
|
Decision Trees | 2 | 1998 | 509 | 0.050 |
Why?
|
Attitude of Health Personnel | 1 | 1997 | 3928 | 0.050 |
Why?
|
Interleukin-15 | 1 | 2023 | 186 | 0.050 |
Why?
|
Quality of Health Care | 1 | 1998 | 4339 | 0.050 |
Why?
|
Methicillin | 1 | 2022 | 62 | 0.050 |
Why?
|
Linkage Disequilibrium | 2 | 2004 | 2000 | 0.050 |
Why?
|
Influenza B virus | 1 | 2022 | 53 | 0.050 |
Why?
|
Multivariate Analysis | 2 | 2013 | 12095 | 0.050 |
Why?
|
Aspirin | 1 | 2014 | 3135 | 0.050 |
Why?
|
Quality Control | 1 | 2005 | 836 | 0.050 |
Why?
|
Inheritance Patterns | 1 | 2004 | 344 | 0.050 |
Why?
|
Mothers | 2 | 2023 | 2209 | 0.050 |
Why?
|
Influenza A Virus, H3N2 Subtype | 1 | 2022 | 85 | 0.050 |
Why?
|
Follow-Up Studies | 3 | 2014 | 39394 | 0.050 |
Why?
|
Leukocytosis | 1 | 2023 | 251 | 0.050 |
Why?
|
Rehabilitation | 1 | 2003 | 129 | 0.050 |
Why?
|
Chemotactic Factors | 1 | 2022 | 197 | 0.050 |
Why?
|
Blood | 1 | 2004 | 599 | 0.050 |
Why?
|
Pulmonary Surfactant-Associated Protein D | 1 | 2021 | 49 | 0.050 |
Why?
|
HLA-DR Antigens | 1 | 2023 | 609 | 0.050 |
Why?
|
Orthomyxoviridae Infections | 1 | 2024 | 255 | 0.050 |
Why?
|
Crowding | 1 | 2023 | 144 | 0.050 |
Why?
|
Staphylococcus aureus | 2 | 2022 | 1430 | 0.050 |
Why?
|
Physicians, Women | 1 | 2008 | 521 | 0.050 |
Why?
|
Patients | 1 | 2008 | 908 | 0.050 |
Why?
|
Neoplasms | 2 | 2022 | 22389 | 0.050 |
Why?
|
Costs and Cost Analysis | 1 | 2007 | 1669 | 0.050 |
Why?
|
Lymphocyte Count | 1 | 2023 | 794 | 0.050 |
Why?
|
Risk Assessment | 5 | 2014 | 24333 | 0.050 |
Why?
|
Oxygen | 1 | 2012 | 4272 | 0.050 |
Why?
|
Gene Expression Profiling | 3 | 2023 | 9549 | 0.050 |
Why?
|
Erythrocytes | 1 | 2010 | 2421 | 0.040 |
Why?
|
Stroke | 1 | 2023 | 9756 | 0.040 |
Why?
|
Respiratory Mechanics | 1 | 2004 | 722 | 0.040 |
Why?
|
Odds Ratio | 1 | 2012 | 9684 | 0.040 |
Why?
|
Linear Models | 2 | 2023 | 5891 | 0.040 |
Why?
|
Influenza in Birds | 1 | 2020 | 76 | 0.040 |
Why?
|
North America | 2 | 2016 | 1290 | 0.040 |
Why?
|
Automation | 1 | 2002 | 589 | 0.040 |
Why?
|
Birds | 1 | 2020 | 166 | 0.040 |
Why?
|
Hematologic Neoplasms | 1 | 2011 | 1907 | 0.040 |
Why?
|
Receptor, Notch1 | 1 | 2023 | 520 | 0.040 |
Why?
|
Immunization, Passive | 1 | 2022 | 619 | 0.040 |
Why?
|
Sex Distribution | 1 | 2004 | 2280 | 0.040 |
Why?
|
Faculty, Medical | 1 | 2008 | 1226 | 0.040 |
Why?
|
Hemodynamics | 2 | 2020 | 4199 | 0.040 |
Why?
|
Reproducibility of Results | 4 | 2005 | 20245 | 0.040 |
Why?
|
Immunization, Secondary | 1 | 2022 | 373 | 0.040 |
Why?
|
Immunoassay | 1 | 2022 | 746 | 0.040 |
Why?
|
Coronary Care Units | 1 | 2020 | 235 | 0.040 |
Why?
|
Shock | 1 | 2021 | 316 | 0.040 |
Why?
|
Organizational Innovation | 1 | 2002 | 540 | 0.040 |
Why?
|
Subclavian Vein | 1 | 1998 | 57 | 0.040 |
Why?
|
High-Frequency Ventilation | 1 | 2019 | 90 | 0.040 |
Why?
|
Viral Envelope Proteins | 1 | 2022 | 641 | 0.040 |
Why?
|
Anemia | 1 | 2008 | 1517 | 0.040 |
Why?
|
Antigens, Viral | 1 | 2022 | 996 | 0.040 |
Why?
|
Human Experimentation | 1 | 1999 | 125 | 0.040 |
Why?
|
Hypermedia | 1 | 1998 | 21 | 0.040 |
Why?
|
Interleukin-10 | 1 | 2004 | 1183 | 0.040 |
Why?
|
Phlebitis | 1 | 1998 | 35 | 0.040 |
Why?
|
APACHE | 1 | 1998 | 268 | 0.040 |
Why?
|
Antisepsis | 2 | 2011 | 16 | 0.040 |
Why?
|
Infusions, Intra-Arterial | 1 | 1998 | 221 | 0.040 |
Why?
|
Adenosine | 1 | 2023 | 822 | 0.040 |
Why?
|
Family Characteristics | 1 | 2023 | 1004 | 0.040 |
Why?
|
Diagnosis, Differential | 2 | 2021 | 13021 | 0.040 |
Why?
|
Nasal Lavage Fluid | 1 | 2017 | 17 | 0.040 |
Why?
|
Angiopoietin-2 | 1 | 2019 | 186 | 0.040 |
Why?
|
Proteins | 1 | 2012 | 6011 | 0.040 |
Why?
|
Reference Standards | 1 | 2021 | 1014 | 0.040 |
Why?
|
Mice | 5 | 2024 | 82072 | 0.040 |
Why?
|
Intensive Care Units, Neonatal | 1 | 2004 | 862 | 0.040 |
Why?
|
Efficiency, Organizational | 1 | 2002 | 699 | 0.040 |
Why?
|
Jugular Veins | 1 | 1998 | 211 | 0.030 |
Why?
|
Brazil | 1 | 2021 | 1250 | 0.030 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2023 | 4651 | 0.030 |
Why?
|
Information Services | 1 | 1998 | 239 | 0.030 |
Why?
|
Phagocytosis | 1 | 2023 | 1530 | 0.030 |
Why?
|
Tissue Donors | 1 | 2007 | 2382 | 0.030 |
Why?
|
Health Care Surveys | 1 | 2004 | 2437 | 0.030 |
Why?
|
Terminology as Topic | 1 | 2004 | 1541 | 0.030 |
Why?
|
Pedigree | 1 | 2004 | 4545 | 0.030 |
Why?
|
Animal Experimentation | 1 | 2016 | 46 | 0.030 |
Why?
|
Adenosine Triphosphate | 1 | 2023 | 2003 | 0.030 |
Why?
|
Virus Replication | 1 | 2024 | 2458 | 0.030 |
Why?
|
Early Diagnosis | 1 | 2021 | 1194 | 0.030 |
Why?
|
Paracentesis | 1 | 2016 | 99 | 0.030 |
Why?
|
Interleukin-8 | 1 | 2019 | 705 | 0.030 |
Why?
|
T-Lymphocytes | 2 | 2024 | 10276 | 0.030 |
Why?
|
Methicillin Resistance | 1 | 2016 | 198 | 0.030 |
Why?
|
Reference Values | 1 | 2003 | 4940 | 0.030 |
Why?
|
Interferon-alpha | 1 | 2020 | 910 | 0.030 |
Why?
|
Equipment Failure | 1 | 1998 | 585 | 0.030 |
Why?
|
Antibodies | 1 | 2023 | 2422 | 0.030 |
Why?
|
Phosphoproteins | 1 | 2024 | 2452 | 0.030 |
Why?
|
Polydeoxyribonucleotides | 1 | 2016 | 136 | 0.030 |
Why?
|
Mucocutaneous Lymph Node Syndrome | 1 | 2020 | 539 | 0.030 |
Why?
|
Chi-Square Distribution | 2 | 2012 | 3438 | 0.030 |
Why?
|
S100 Proteins | 1 | 2015 | 217 | 0.030 |
Why?
|
Wound Infection | 1 | 1997 | 243 | 0.030 |
Why?
|
Minority Groups | 1 | 2022 | 1216 | 0.030 |
Why?
|
von Willebrand Factor | 1 | 2019 | 680 | 0.030 |
Why?
|
Stromal Cells | 1 | 2020 | 1337 | 0.030 |
Why?
|
Viral Load | 1 | 2024 | 3398 | 0.030 |
Why?
|
Animals | 7 | 2024 | 169335 | 0.030 |
Why?
|
Pilot Projects | 2 | 2022 | 8748 | 0.030 |
Why?
|
Body Fluids | 1 | 2016 | 322 | 0.030 |
Why?
|
Documentation | 1 | 2021 | 917 | 0.030 |
Why?
|
Hypnotics and Sedatives | 1 | 2002 | 1191 | 0.030 |
Why?
|
Carbon Dioxide | 1 | 2019 | 1149 | 0.030 |
Why?
|
Lactic Acid | 1 | 2020 | 1140 | 0.030 |
Why?
|
Vasodilator Agents | 1 | 2019 | 990 | 0.030 |
Why?
|
Electronic Health Records | 2 | 2023 | 4879 | 0.030 |
Why?
|
Research | 1 | 2003 | 1981 | 0.030 |
Why?
|
Antiemetics | 1 | 2016 | 188 | 0.030 |
Why?
|
Positive-Pressure Respiration | 1 | 2019 | 713 | 0.030 |
Why?
|
Cadherins | 1 | 2019 | 906 | 0.030 |
Why?
|
Mass Screening | 1 | 1990 | 5457 | 0.030 |
Why?
|
Decision Making | 2 | 1999 | 3953 | 0.030 |
Why?
|
Interferon-gamma | 1 | 2022 | 3163 | 0.030 |
Why?
|
Nitric Oxide | 1 | 2023 | 2149 | 0.030 |
Why?
|
Registries | 1 | 2010 | 8384 | 0.030 |
Why?
|
Antibodies, Neutralizing | 1 | 2023 | 2009 | 0.030 |
Why?
|
Teaching Materials | 1 | 1994 | 86 | 0.030 |
Why?
|
Platelet Count | 1 | 2016 | 787 | 0.030 |
Why?
|
Canada | 2 | 2010 | 2130 | 0.030 |
Why?
|
Phylogeny | 1 | 2021 | 2843 | 0.030 |
Why?
|
Propensity Score | 1 | 2021 | 1968 | 0.030 |
Why?
|
Diuretics | 1 | 2016 | 614 | 0.030 |
Why?
|
Analysis of Variance | 2 | 2012 | 6236 | 0.030 |
Why?
|
Oxygen Inhalation Therapy | 1 | 1996 | 417 | 0.030 |
Why?
|
Ethics, Research | 1 | 2014 | 178 | 0.030 |
Why?
|
Sex Factors | 2 | 2008 | 10633 | 0.030 |
Why?
|
Extracellular Matrix | 1 | 2020 | 1739 | 0.030 |
Why?
|
Risk | 3 | 2002 | 9621 | 0.030 |
Why?
|
Partial Pressure | 1 | 2012 | 248 | 0.030 |
Why?
|
Arrhythmias, Cardiac | 1 | 2022 | 2258 | 0.030 |
Why?
|
Selection Bias | 1 | 2014 | 360 | 0.030 |
Why?
|
Prone Position | 1 | 2013 | 203 | 0.030 |
Why?
|
Weight Gain | 1 | 2022 | 2359 | 0.020 |
Why?
|
Blood Gas Analysis | 1 | 2013 | 384 | 0.020 |
Why?
|
Hypercapnia | 1 | 2013 | 260 | 0.020 |
Why?
|
Delivery of Health Care | 2 | 2022 | 5375 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2003 | 5323 | 0.020 |
Why?
|
Inflammation | 2 | 2023 | 10868 | 0.020 |
Why?
|
Base Sequence | 1 | 2022 | 12430 | 0.020 |
Why?
|
Chest Pain | 1 | 1998 | 1101 | 0.020 |
Why?
|
Membrane Glycoproteins | 1 | 2022 | 3713 | 0.020 |
Why?
|
User-Computer Interface | 1 | 1998 | 1406 | 0.020 |
Why?
|
C-Reactive Protein | 1 | 2023 | 3859 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2021 | 6320 | 0.020 |
Why?
|
Inpatients | 1 | 2023 | 2569 | 0.020 |
Why?
|
Retreatment | 1 | 2012 | 600 | 0.020 |
Why?
|
Alcohols | 1 | 2011 | 94 | 0.020 |
Why?
|
Epidemiologic Research Design | 1 | 2014 | 368 | 0.020 |
Why?
|
Bradycardia | 1 | 2012 | 305 | 0.020 |
Why?
|
Materials Management, Hospital | 1 | 2010 | 8 | 0.020 |
Why?
|
Gene Expression | 1 | 2023 | 7603 | 0.020 |
Why?
|
Esterases | 1 | 1990 | 89 | 0.020 |
Why?
|
Obesity | 2 | 2023 | 13091 | 0.020 |
Why?
|
Neutrophils | 1 | 2023 | 3785 | 0.020 |
Why?
|
Aged | 5 | 2023 | 171786 | 0.020 |
Why?
|
Blotting, Western | 1 | 2017 | 5033 | 0.020 |
Why?
|
Chlorhexidine | 1 | 2011 | 159 | 0.020 |
Why?
|
Colony Count, Microbial | 1 | 1990 | 328 | 0.020 |
Why?
|
Macrophages | 1 | 2024 | 5801 | 0.020 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2023 | 3116 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2020 | 2542 | 0.020 |
Why?
|
Quantitative Trait Loci | 1 | 2017 | 2133 | 0.020 |
Why?
|
ROC Curve | 1 | 1997 | 3629 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2024 | 14484 | 0.020 |
Why?
|
Reagent Kits, Diagnostic | 1 | 1990 | 239 | 0.020 |
Why?
|
Chlamydia trachomatis | 1 | 1990 | 239 | 0.020 |
Why?
|
Administration, Oral | 1 | 1996 | 4040 | 0.020 |
Why?
|
Antigens, CD | 1 | 2019 | 4032 | 0.020 |
Why?
|
Infant Mortality | 1 | 1993 | 754 | 0.020 |
Why?
|
Radiography | 1 | 2019 | 6991 | 0.020 |
Why?
|
Morbidity | 1 | 1993 | 1757 | 0.020 |
Why?
|
Activities of Daily Living | 1 | 1997 | 2434 | 0.020 |
Why?
|
Health Personnel | 2 | 2011 | 3383 | 0.020 |
Why?
|
Terminal Care | 1 | 1999 | 1772 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 4592 | 0.020 |
Why?
|
Blood Specimen Collection | 1 | 2008 | 238 | 0.020 |
Why?
|
Signal Transduction | 2 | 2020 | 23653 | 0.020 |
Why?
|
Drug Combinations | 1 | 2012 | 2089 | 0.020 |
Why?
|
Brain Injuries | 1 | 1998 | 2058 | 0.020 |
Why?
|
Mutation | 2 | 2021 | 30266 | 0.020 |
Why?
|
Alleles | 1 | 2017 | 6901 | 0.020 |
Why?
|
Immunotherapy | 1 | 2022 | 4756 | 0.020 |
Why?
|
Family | 1 | 1997 | 3208 | 0.020 |
Why?
|
Mice, Inbred C57BL | 1 | 2024 | 22379 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 1990 | 2474 | 0.020 |
Why?
|
Disease Management | 1 | 2016 | 2537 | 0.020 |
Why?
|
Demography | 1 | 2010 | 1642 | 0.020 |
Why?
|
Thrombolytic Therapy | 1 | 2014 | 2055 | 0.020 |
Why?
|
Bayes Theorem | 1 | 2012 | 2360 | 0.010 |
Why?
|
Recurrence | 1 | 1996 | 8513 | 0.010 |
Why?
|
Europe | 1 | 2010 | 3441 | 0.010 |
Why?
|
Awards and Prizes | 1 | 2008 | 365 | 0.010 |
Why?
|
Health Care Costs | 1 | 1996 | 3270 | 0.010 |
Why?
|
Blood Pressure Monitors | 1 | 2002 | 33 | 0.010 |
Why?
|
DNA Methylation | 1 | 2017 | 4432 | 0.010 |
Why?
|
Umbilical Arteries | 1 | 2002 | 77 | 0.010 |
Why?
|
Lymphoma | 1 | 2011 | 1900 | 0.010 |
Why?
|
Pregnancy Outcome | 1 | 1993 | 2974 | 0.010 |
Why?
|
Respiratory Hypersensitivity | 1 | 2004 | 272 | 0.010 |
Why?
|
Leukocytes | 1 | 1990 | 2034 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2021 | 12801 | 0.010 |
Why?
|
Dexamethasone | 1 | 2009 | 1965 | 0.010 |
Why?
|
3' Untranslated Regions | 1 | 2004 | 515 | 0.010 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2004 | 640 | 0.010 |
Why?
|
Schools, Medical | 1 | 2008 | 883 | 0.010 |
Why?
|
Introns | 1 | 2004 | 969 | 0.010 |
Why?
|
Forecasting | 1 | 2010 | 2945 | 0.010 |
Why?
|
Aged, 80 and over | 2 | 2019 | 59739 | 0.010 |
Why?
|
Guideline Adherence | 1 | 2011 | 2241 | 0.010 |
Why?
|
Parents | 1 | 2014 | 3597 | 0.010 |
Why?
|
Curriculum | 1 | 1994 | 3782 | 0.010 |
Why?
|
Anti-Infective Agents, Local | 1 | 2002 | 247 | 0.010 |
Why?
|
Anti-Inflammatory Agents | 1 | 2009 | 1811 | 0.010 |
Why?
|
Time Factors | 2 | 2012 | 40261 | 0.010 |
Why?
|
Professional Staff Committees | 1 | 1999 | 37 | 0.010 |
Why?
|
Ethical Review | 1 | 1999 | 27 | 0.010 |
Why?
|
Therapeutic Human Experimentation | 1 | 1999 | 43 | 0.010 |
Why?
|
Control Groups | 1 | 1999 | 107 | 0.010 |
Why?
|
Forced Expiratory Volume | 1 | 2004 | 1831 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2012 | 12467 | 0.010 |
Why?
|
Middle Aged | 3 | 2019 | 223737 | 0.010 |
Why?
|
International Cooperation | 1 | 2005 | 1436 | 0.010 |
Why?
|
Myocardial Infarction | 1 | 1998 | 11521 | 0.010 |
Why?
|
Skin | 1 | 2011 | 4506 | 0.010 |
Why?
|
Antibiotic Prophylaxis | 1 | 2002 | 641 | 0.010 |
Why?
|
Research Subjects | 1 | 1999 | 249 | 0.010 |
Why?
|
Patient Advocacy | 1 | 1999 | 362 | 0.010 |
Why?
|
Personal Autonomy | 1 | 1999 | 315 | 0.010 |
Why?
|
Home Care Services | 1 | 2002 | 660 | 0.010 |
Why?
|
Chromosome Mapping | 1 | 2004 | 4625 | 0.010 |
Why?
|
Uncertainty | 1 | 1999 | 769 | 0.010 |
Why?
|
Models, Genetic | 1 | 2004 | 3449 | 0.010 |
Why?
|
Internship and Residency | 1 | 1994 | 5956 | 0.010 |
Why?
|
Ambulatory Care | 1 | 2002 | 2784 | 0.010 |
Why?
|
Genetic Testing | 1 | 2004 | 3591 | 0.010 |
Why?
|
Hospitals | 1 | 2002 | 3904 | 0.010 |
Why?
|
Artificial Intelligence | 1 | 1996 | 2666 | 0.000 |
Why?
|